Which hedge funds own CPIX? CUMBERLAND PHARMACEUTICALS I, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in CPIX (CUMBERLAND PHARMACEUTICALS I) in their Q2 2026 13F filings, worth $5.4m in total. The largest holder by portfolio weight is Ikarian Capital, LLC at 0.5% of its book. 1 exited: J. Goldman & CO LP.
6tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold CPIX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | Q2 2026 | 0.5% | $3.3m | 503,153 | -9% | reduced |
| Boothbay Fund Management, LLC | Q2 2026 | 0.0% | $729.3k | 112,544 | -12% | reduced |
| Perceptive Advisors LLC | Q2 2026 | 0.0% | $628.4k | 96,982 | -51% | reduced |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $475.6k | 73,391 | 341% | added |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $155.4k | 23,981 | 116% | added |
| Arrowstreet Capital, Limited Partnership | Q2 2026 | 0.0% | $131.2k | 20,252 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| J. Goldman & CO LP | 0.0% | $263.4k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of CPIX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $8.5m |
| Q1 2026 | 8 | $4.8m |
| Q4 2025 | 1 | $1.9m |
| Q3 2025 | 1 | $1.6m |
| Q2 2025 | 1 | $1.7m |
| Q1 2025 | 1 | $2.1m |
| Q4 2024 | 1 | $1.2m |
| Q3 2024 | 1 | $676.0k |
| Q2 2024 | 1 | $823.4k |
| Q1 2024 | 1 | $912.0k |
| Q4 2023 | 1 | $985.0k |
| Q3 2023 | 1 | $1.1m |
| Q2 2023 | 1 | $824.0k |
| Q1 2023 | 1 | $1.1m |
| Q4 2022 | 1 | $1.3m |
| Q3 2022 | 1 | $1.4m |
Counts every tracked manager that disclosed CPIX in that quarter's filing, including managers that have since stopped filing.